People receiving talking therapy for mild to severe depression reported greater improvements to their symptoms when also taking creatine compared with those on a placebo ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

Scientists at Virginia Tech are revolutionizing depression treatment by tapping into how the brain processes rewards. Their ...

Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the ...

Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the ...

Ketamine therapy has become known for its effects at combating depression and other mood disorders. There’s a growing body of ...

And a large-scale study Professor Jacka co-authored last year showed Mediterranean diets may prevent depression as well as treat it. Data from 3,000 adults showed that, after six years ...

Depression is prevalent in children, requiring early diagnosis and treatment. Learn about child depression symptoms, causes ...

The approval of Spravato for the monotherapy indication in TRD was supported by data from the randomized, double-blind, ...

A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression ...